Corcept Therapeutics (CORT) Current Leases (2019 - 2025)
Historic Current Leases for Corcept Therapeutics (CORT) over the last 7 years, with Q3 2025 value amounting to $1.0 million.
- Corcept Therapeutics' Current Leases rose 14305.56% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 14305.56%. This contributed to the annual value of $829000.0 for FY2024, which is 44900.66% up from last year.
- As of Q3 2025, Corcept Therapeutics' Current Leases stood at $1.0 million, which was up 14305.56% from $1.0 million recorded in Q2 2025.
- In the past 5 years, Corcept Therapeutics' Current Leases ranged from a high of $2.3 million in Q1 2022 and a low of $44000.0 during Q2 2024
- Over the past 5 years, Corcept Therapeutics' median Current Leases value was $984000.0 (recorded in 2025), while the average stood at $960842.1.
- Its Current Leases has fluctuated over the past 5 years, first crashed by 8688.16% in 2023, then skyrocketed by 221136.36% in 2025.
- Over the past 5 years, Corcept Therapeutics' Current Leases (Quarter) stood at $526000.0 in 2021, then skyrocketed by 117.3% to $1.1 million in 2022, then tumbled by 86.79% to $151000.0 in 2023, then soared by 449.01% to $829000.0 in 2024, then increased by 26.66% to $1.0 million in 2025.
- Its Current Leases was $1.0 million in Q3 2025, compared to $1.0 million in Q2 2025 and $984000.0 in Q1 2025.